Aytu BioPharma (NASDAQ:AYTU – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.82) EPS for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.37), Zacks reports. Aytu BioPharma had a negative return on equity of 31.31% and a negative net margin of 14.60%.
Aytu BioPharma Trading Up 17.2 %
NASDAQ:AYTU opened at $2.85 on Friday. The company has a 50-day moving average of $2.53 and a 200-day moving average of $2.83. Aytu BioPharma has a twelve month low of $1.66 and a twelve month high of $3.50. The firm has a market cap of $17.01 million, a price-to-earnings ratio of -1.08 and a beta of -1.43.
Aytu BioPharma Company Profile
Featured Articles
- Five stocks we like better than Aytu BioPharma
- How to Invest in Small Cap Stocks
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- What Intuitive Machines’ Big NASA Contract Means for Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- REITs on the Rise After Rate Cuts: Where to Invest Now
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.